近期,广东东阳光药业股份有限公司(以下简称“东阳光药”)向港交所提交上市申请并通过聆讯,计划于8月7日以股票代码“06887”挂牌交易,有望成为首单H股吸收合并私有化加介绍上市的案例。其招股书内容不只是企业宣传,而是清晰呈现了其在技术、国际化与政策体系下的一系列实质进展。一、起点:从爆款单品起家可威是东阳光药一手打造起来的名牌,也为其自身提供了丰沛的现金流。2006年,东阳光药获得罗氏授权,以...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.